Walsh Tony G, Poole Alastair W
School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, BS8 1TD, United Kingdom.
TH Open. 2017 Jun 28;1(1):e24-32. doi: 10.1055/s-0037-1603928.
Platelets are classically known for their roles in bleeding control and occlusive thrombus formation causing ischaemic tissue damage. Recently non-classical roles for platelets have been described, many of which may be mediated by the heterogeneous cargo that platelets secrete from granular stores upon activation. Using an model of ischaemic injury to ventricular cardiomyocytes, we observed that platelets, through secreted factors, delayed the rate of cardiomyocyte death during ischaemia. This protective effect appeared independent of platelet dense granule cargo, but required α-granule components stromal cell-derived factor (SDF)-1α and transforming growth factor (TGF) β1. Protein kinase C (PKC) activity within cardiomyocytes was responsible for mediating the protective signals initiated by the released platelet cargo. Importantly, pretreating platelets with a P2Y antagonist, but not the cyclooxygenase inhibitor aspirin, substantially attenuated this protective effect. These findings therefore reveal a paradoxically protective role for platelet activation during cardiac ischaemia and could have important implications for the use of anti-platelet therapeutics in the management of myocardial infarction.
血小板在止血和形成闭塞性血栓导致缺血性组织损伤方面的作用广为人知。最近,血小板的非经典作用也被发现,其中许多作用可能由血小板激活时从颗粒储存中分泌的异质物质介导。使用心室心肌细胞缺血损伤模型,我们观察到血小板通过分泌因子在缺血期间延缓了心肌细胞死亡的速度。这种保护作用似乎独立于血小板致密颗粒物质,但需要α颗粒成分基质细胞衍生因子(SDF)-1α和转化生长因子(TGF)β1。心肌细胞内的蛋白激酶C(PKC)活性负责介导由释放的血小板物质引发的保护信号。重要的是,用P2Y拮抗剂预处理血小板,但不是环氧合酶抑制剂阿司匹林,会显著减弱这种保护作用。因此,这些发现揭示了血小板激活在心脏缺血期间具有矛盾的保护作用,这可能对抗血小板治疗在心肌梗死管理中的应用具有重要意义。